You’ve probably heard of hemophilia — with its history among European royalty — but maybe not about von Willebrand disease, the much more common bleeding disorder affecting up to 1 percent of the U.S.

AvWD is a rare type of bleeding disorder where blood does not clot correctly. It typically develops alongside other health conditions that affect the heart, immune system, or blood cells. Von ...

Blood has many functions and circulates throughout your body. As a result, problems with it can affect you in many ways. Some of those problems can stem from a blood disorder. These disorders can ...

The U.S. Food and Drug Administration has approved expanded use of Vonvendi (von Willebrand factor [recombinant]) for routine ...

When it comes to bleeding disorders, most people have heard of hemophilia. It's rare and almost always affects only males. But Von Willebrand Disease is the most common inherited bleeding disorder and ...

Scientists at the RCSI University of Medicine and Health Sciences in Dublin, Ireland, have discovered a new role for the blood clotting protein, von Willebrand Factor (VWF), that could lead to the ...

Von Willebrand factor (VWF) is a protein crucial to the blood clotting process. If you don’t have enough of this protein, or if it doesn’t work as it’s supposed to, you may have von Willebrand disease ...

The foundation helps people with hemophilia, Von Willebrand disease and other conditions that cause their blood not to clot ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Vega Therapeutics, Inc., a clinical stage biotechnology company developing novel therapies for rare blood disorders, today announced that its clinical ...

Experts do not recommend people with von Willebrand disease avoid any specific foods. They need to eat a balanced and varied diet and speak with a doctor if they have any dietary concerns. Von ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Despite ...

Takeda (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has approved the supplemental ...